Nutrition 21 Presents Three Preclinical Scientific Studies on Velositol at ISSN

Nutrition 21 Presents Three Preclinical Scientific Studies on Velositol at ISSN

NEW YORK, NY – (Marketwired – June 28, 2017)
James Komorowski, MS, CNS, vice president of scientific and regulatory affairs at Nutrition 21, presented the results of three preclinical studies on Nutrition 21’s patented amylopectin and chromium combination ingredient, Velositol, at the ISSN (International Society of Sports Nutrition) conference on June 24th in Phoenix.
Read the full press release here – Nutrition 21 Presents Three Preclinical Scientific Studies on Velositol at ISSM


To find out more about Velositol, visit http://www.velositol.com